Welcome to Wehale.life - website about asthma and COPD (chronic obstructive pulmonary disease). This section is intended for healthcare professionals treating people with respiratory conditions. Depending on the country you might have to register to get access.
Choose your local article below - or scroll down to choose your country. Read more about wehale.life content for Healthcare Professionals
Orion Pharma and Menarini warmly welcome all healthcare professionals to the jointly organized virtual symposium, Successful inhalation therapy in 2020: patients and inhalers in focus. The symposium, chaired by Professor Eric Bateman, is available for all registered ERS participants. Read more and register now
Real-world studies can provide valuable information on patient experience and satisfaction with the inhaler, as well as on clinical efficacy and adherence to inhaled treatment in daily use. Read about the efficacy of combination therapy in bronchial asthma as evaluated in a Polish real-world study.
Para cumplir con el concepto de un inhalador "ideal", el dispositivo debe albergar una serie de características entre las que se encuentran ser efectivo, cómodo, versátil y ecológico.
Real-world studies are essential in comparing different inhalers in daily use and assessing the grounds of poor asthma and COPD control. How does inhaler switch affect patient satisfaction and disease control in real-world clinical practice? Explore the real-world results.
It is essential that an inhaler maintains its performance even when exposed to environmental stress conditions such as varying temperature, humidity and dropping. Read about the performance of Orion’s DPI under simulated real-world conditions.
Pharmacokinetic measures of lung deposition and systemic exposure of medication can help to evaluate and compare the efficacy and safety of inhaled therapy with different inhalers. Read more about pharmacokinetic bioequivalence study of Orion’s DPI and the originator product.
Tutkimuksen mukaan kuivajauheinhalaattoria käyttävät potilaat olivat huomattavasti tyytyväisempiä hoitoonsa kuin ponnekaasuaerosolia käyttävät potilaat.
Informationen zum umgang mit asthma und COPD in coronazeiten